These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 19149693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
    Lee H, Ko KS, Song JH, Peck KR.
    Microb Drug Resist; 2011 Mar; 17(1):37-45. PubMed ID: 20950191
    [Abstract] [Full Text] [Related]

  • 6. Comparative review of the carbapenems.
    Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA.
    Drugs; 2007 Mar; 67(7):1027-52. PubMed ID: 17488146
    [Abstract] [Full Text] [Related]

  • 7. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ, Lancaster JW.
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
    Kiratisin P, Chongthaleong A, Tan TY, Lagamayo E, Roberts S, Garcia J, Davies T.
    Int J Antimicrob Agents; 2012 Apr; 39(4):311-6. PubMed ID: 22386743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety of intravenous infusion of doripenem.
    Redman R, File TM.
    Clin Infect Dis; 2009 Aug 15; 49 Suppl 1():S28-35. PubMed ID: 19619019
    [Abstract] [Full Text] [Related]

  • 13. Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.
    Kiratisin P, Keel RA, Nicolau DP.
    Int J Antimicrob Agents; 2013 Jan 15; 41(1):47-51. PubMed ID: 23127484
    [Abstract] [Full Text] [Related]

  • 14. [Doripenem: need for a new carbapenem].
    Guery BP.
    Med Mal Infect; 2009 Dec 15; 39(12):871-6. PubMed ID: 19875257
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR, Jacobus NV, McDermott LA.
    Antimicrob Agents Chemother; 2008 Dec 15; 52(12):4492-6. PubMed ID: 18838581
    [Abstract] [Full Text] [Related]

  • 19. Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
    Micaëlo M, Brossier F, Bréchot N, Luyt CE, Lu Q, Monsel A, Jarlier V, Aubry A.
    Med Mal Infect; 2018 Aug 15; 48(5):365-371. PubMed ID: 29628176
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.